SG3 Management’s CME Group CME Stock Holding History

SG3 Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-20,000	Closed	-$2.92M	–	95
2017 Q4	$2.92M	Buy	+20,000	New	+$2.85M	0.96%	24

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

SG3 Management's CME Position: Q1 2017 in Review

SG3 Management sold out of CME Group (CME) in Q1 2017, closing a stake of 1,500 shares — an estimated $173K sold.

SG3 Management first reported a position in CME in Q4 2016 and held it in 1 quarter. The position peaked at $173K in Q4 2016. 763 funds tracked by Wall St. Rank hold CME as of Q1 2017.

SG3 Management reported no remaining CME Group position as of Q1 2017 after selling out during the quarter.
SG3 Management sold 1,500 CME Group shares in Q1 2017, an estimated $173K.
SG3 Management first reported a position in CME Group in Q4 2016 and held it in 1 quarter.
SG3 Management's CME Group position peaked at $173K in Q4 2016.
763 funds tracked by Wall St. Rank held CME Group as of Q1 2017.

Based on SG3 Management's 13F filing for Q1 2017, filed 25 Jan 2018.